08:25 EST AnaptysBio (ANAB) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on ANAB: AnaptysBio downgraded to Neutral from Buy at BTIG AnaptysBio price target lowered to $66 from $75 at JPMorgan AnaptysBio price target lowered to $52 from $55 at H.C. Wainwright AnaptysBio Reports Q3 2024 Financial Results and Updates AnaptysBio reports Q3 EPS ($1.14), consensus ($1.65) Disclaimer & DisclosureReport an Issue
